Key result
Surgical resection of primary cardiac dedifferentiated liposarcoma is challenged by rapid in-situ recurrence.
Why the study?
The prognosis of primary malignant cardiac dedifferentiated liposarcoma is extremely poor due to recurrence and distant metastasis, posing challenges for cardiac surgeons.
Case Report (n=1)
Primary cardiac dedifferentiated liposarcoma is a rare malignant tumor with a high risk of repeated in-situ recurrence after resection, posing a significant challenge for cardiac surgeons.
Alerts surgeons to recurrence challenges in rare tumors; leaves open optimal long-term strategies.
Dedifferentiated liposarcoma (DDLPS) is a rare type of neoplasm which can originally rise in cardiac chamber. Owing to the recurrence and distant metastasis, the prognosis of the primary malignant cardiac tumor is extremely poor and remains a challenge for cardiac surgeons. Here, we report a patient with an intracavitary mass which was diagnosed as DDLPS by postoperative pathological examinations, experienced repeated in-situ recurrence of the malignant cardiac tumor.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2019) conducted a case report in Primary cardiac dedifferentiated liposarcoma (DDLPS) (n=1). Surgical resection was evaluated on In-situ recurrence. A patient with primary cardiac dedifferentiated liposarcoma experienced repeated in-situ recurrence after surgical resection, highlighting the poor prognosis and challenges in managing this rare tumor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: